on 'Contract Manufacturing'

1-20 of 146 < first | prev | | last >
  • China's Biopharma Growth: Can it Continue?

    A new study shows a projected doubling of sales volume by 2021, as China strives to catch up with the global market

    Vicky (Qing) Xia, Senior Project Director, BioPlan Associates
  • Many Knives in the Air

    Contract manufacturers use their talents to juggle the risks of multi-product manufacturing

    Karen Langhauser, Chief Content Director
  • Cutting-Edge Flexibility

    CDMOs perfect the art of survival in today’s multi-product world

    Karen Langhauser, Chief Content Director
  • EU FMD: The One-Year Countdown

    Companies that manufacture, sell or dispense drugs in the European Union have until February 9, 2019 to comply. Where does the industry stand?

    Pharmaceutical Manufacturing staff
  • The Evolving Biopharma Contract-Manufacturing Market

    Once biopharma companies optimize operations in order to free up hidden capacity, they have four options: build, acquire, partner or face the realities of outsourcing

    Andrea Gennari, Martin Loesch, Alberto Santagostino and Ralf Otto, McKinsey & Co.
  • Inking the Deal

    Mastering the art of lasting outsourcing relationships in the pharmaceutical industry

    Karen Langhauser, Chief Content Director
  • The Art of the Request for Proposals

    A well-written RFP and effectively managed process is well worth the upfront time and effort

    Ron Herman, Senior Partner, NexGen Consulting Group, LLC
  • Managing Regulatory Inspections: A CDMO Perspective

    Inspection success begins with awareness of the challenges and obstacles, and continues with ongoing preparation and frequent inspection readiness

    Joachim del Boca, VP of Regulatory Affairs/Quality Compliance, Vetter Pharma-Fertigung GmbH & Co. KG
  • Next-Generation Innovation

    Streamlined strategies secure pharma’s future as the industry thinks outside the pill box

    Karen Langhauser, Chief Content Director
1-20 of 146 < first | prev | | last >